We recently passed the milestone of supporting practices that cover over 500,000 patients. Thank you for all your support, recommendations, feedback, and ideas – it's great to work with you all and to support so many great practices!

Several developments from our end related to this…

• Getting Help - We’re growing our team of support staff/trainers. We want a team that works in primary care and uses the system. This makes them better at supporting you, but this means they all have limited availability. Rather than email individuals who’ve supported you, it would be beneficial if you could use our generic email – support@welbyinnovate.co.uk. This email is monitored daily.
• Support Site - We’ve started work on a support site with articles and FAQs you can search https://welbyinnovate-help.freshdesk.com/support/home
• Feedback - We’re finalising the content for our website. We’d really appreciate a couple of minutes of your time to give us feedback. We’d like to know if you’d recommend us but also what we can do to improve - https://bit.ly/WelbyInnovateFeedback
• Rewards for Recommendations - We’re keen to grow and realise nothing counts more than a personal recommendation. If you recommend us to a practice, and they sign up, we will happily give you a £50 Amazon voucher (limit of one recommendation per practice that signs up!). Let us know if you’d like us to present to your PCN / LMC / ICB if you really want to maximise your vouchers!

Recall

• Reducing Monitoring – we’re conscious that our system is good at finding patients who need blood tests but that generates additional work. Following feedback from some of you and a review of clinical guidance, we are making the following changes:
  1. Removed FBC from a number of LTC blood sets (e.g. DM, HTN, lower level CKD)
  2. Switching to ALT instead of full LFTs where clinically appropriate, e.g. statin monitoring or where LFT is included with annual bloods to consider statin initiation. We’re aware that in Lincolnshire, it's not possible to do this so the system will still display LFT. Please let us know if that’s an issue for your lab. For most labs, it is possible and will switch about 2/3rds of LFTs to ALTs.
  3. Stopping monitoring Beta Blockers – these are often prescribed for indications where monitoring is not required. Patients with an HTN diagnosis will have relevant monitoring at the annual review anyway.
  4. Stopping monitoring Folate medication – previously annual folate was done.
  5. Stopping monitoring Crohn's and Colitis unless there are practices that are keen to continue this, in which case it will be an “Opt-in” to monitor them – let us know if you’d like to continue to monitor these.
• Invites – if you want to target Annual Review invites at those who are also due monitoring invites, there are now reports you can use – sections 2d and 3d.
• Request Tests Template – there are new options available for Iron Profile, SHBG, H Pylori and some 2WW blood test groups.
• KPIs – these show you how you’re getting on as a practice and what parts of the system you could be using - https://youtu.be/cEFgUdbHQro
• Questionnaires – if patients call up needing to complete a questionnaire, our template makes it easy to complete with them, or re-send - https://welbyinnovate- help.freshdesk.com/support/solutions/articles/202000074769-how-do-i-complete-or-re-send- questionnaires-to-patients-
• *** Coming Soon *** - option to save appointment lengths by only doing bloods where patients have already had relevant obs, e.g. a hypertensive patient who’s submitted a home BP.
• *** Coming Soon *** - follow-version of our ACQ that can be sent following the change inhalers to check impact without the need for an appointment.

Pathology

• TFT Pathway is now ready to use – its taken a while to sort due to regional variance in lab thresholds. This video gives you a brief intro - https://youtu.be/I6MMzB_TQt8
• Blood Pressure - We’ve created videos for our Blood Pressure protocols which include managing clinic and home BPs, diagnosing Hypertension and medication titration - https://www.youtube.com/playlist?list=PLnDxkJWruFD3azvTB-w4rdjohbIg5x-bu – it triggers automatically on entry of clinical BP so needs enabling. Let us if you’d like to use it for your practice.
• Normal results – we’ve enabled more automated messages to inform patients when individual results are normal and don’t require further action – these now cover UEs, ACRs, HbA1cs, Lipids. Let us know if you’d like more of these enabling.
• Communicating Results – we have a protocol for admin staff to use when patients call up about their results – it will work out what messages need communicating, if all results are back and reviewed, etc. - https://youtu.be/_GjS_N4nAH8
• *** Coming Soon *** - excluding coded/downloaded results from automated messages and systems.

Prescribing

• DOAC Dosing – there are now reports to identify patients who need DOAC dosing changes and we can automate the calculation of CrCl for you. This support article explains more - https://welbyinnovate-help.freshdesk.com/support/solutions/articles/202000074195-how-do-i- review-doac-dosing-
• Questionnaires – You can now send specific medication questionnaires (e.g. POP, HRT review) even if you’ve not opted into including those in annual reviews. They can sent prior to the main invite, once patients have booked, or once everything is completed.
• Childhood Imms – we have invite reports in folder 3a Childhood Imms and a prompt to book these is now included in the admin/reception prompt master.
• Prescribing Pathway – we have a new category for sending general med review questionnaires – patients who have no annual review but are on monitored medication where monitoring is up- to-date, e.g. child on ADHD medication.
• *** Coming Soon *** - flu system for invites and administering flu.